Gonghua Qi
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 2
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 2
-
- PARP inhibition in cancer therapy 5
-
- DNA Repair Mechanisms 4
- RNA modifications and cancer 2
-
- Autophagy in Disease and Therapy 3
-
- Cancer Mechanisms and Therapy 2
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Hanlin MaBeihua KongJiali PengXingsheng YangMargaux J. KanisCunzhong YuanFang HanYingwei Li
- Partner nations
- ChinaUnited States
In The Last Decade
Gonghua Qi
15 papers receiving 361 citations
Peers
Comparison fields: 5 of 46
- Obstetrics and Gynecology 105
- Reproductive Medicine 91
- Cancer Research 73
- Oncology 102
- Molecular Biology 157
Countries citing papers authored by Gonghua Qi
This map shows the geographic impact of Gonghua Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gonghua Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gonghua Qi more than expected).
Fields of papers citing papers by Gonghua Qi
This network shows the impact of papers produced by Gonghua Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gonghua Qi. The network helps show where Gonghua Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gonghua Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 7 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 15 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 31 | |
| 10 | 2022 | 20 | |
| 11 | 2021 | 36 | |
| 12 | CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. | 2021 | 30 |
| 13 | 2020 | 27 | |
| 14 | 2019 | 55 | |
| 15 | 2017 | 64 | |
| 16 | 2017 | 47 |
About Gonghua Qi
Gonghua Qi is a scholar working on Structural Biology, Obstetrics and Gynecology and Reproductive Medicine, having authored 16 papers that have together received 365 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), DNA Repair Mechanisms (4 papers), Autophagy in Disease and Therapy (3 papers), Cancer Mechanisms and Therapy (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Ferroptosis and cancer prognosis (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Obstetrics and Gynecology (105 citations), Reproductive Medicine (91 citations) and Cancer Research (73 citations). Gonghua Qi has collaborated with scholars based in China and United States. Frequent co-authors include Hanlin Ma, Beihua Kong, Jiali Peng, Xingsheng Yang, Margaux J. Kanis, Cunzhong Yuan, Beihua Kong, Fang Han, Yingwei Li and Minghao Li. Their work appears in journals such as Cell Death and Disease, Cell Death Discovery, Oncotarget, Journal of Cellular Physiology and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.